Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 51-100 of 238 result(s).
CYDY CytoDyn Inc
01/10/2022 9:53:22 AM
It's nice to have independent confi (4)
CYDY CytoDyn Inc
01/09/2022 3:02:13 PM
In my layman Sunday afternoon quart (2)
CYDY CytoDyn Inc
01/07/2022 4:16:02 PM
I think we are saying the same thin (2)
CYDY CytoDyn Inc
01/07/2022 11:17:33 AM
I suppose it never hurts to ask abo (17)
CYDY CytoDyn Inc
01/05/2022 2:58:22 PM
My guess is that 700 mg topline res (7)
CYDY CytoDyn Inc
01/05/2022 12:45:03 PM
Is it more difficult or time consu (2)
CYDY CytoDyn Inc
01/05/2022 11:58:52 AM
They clarify at the end we met SE i (6)
CYDY CytoDyn Inc
01/05/2022 11:36:30 AM
Agree, a little confusing and disap (12)
CYDY CytoDyn Inc
01/05/2022 8:56:45 AM
I think it all depends on the stren (5)
CYDY CytoDyn Inc
01/03/2022 12:40:13 PM
It's more the T-cells against the a (4)
CYDY CytoDyn Inc
01/03/2022 11:56:20 AM
We have been involved in many cance (9)
CYDY CytoDyn Inc
12/30/2021 9:46:23 PM
Mechanism of SSRI/other anti-depres (7)
CYDY CytoDyn Inc
12/30/2021 3:05:44 PM
T-cell immunity is more important t (2)
CYDY CytoDyn Inc
12/27/2021 12:03:59 AM
Thanks for sharing your thoughts. M (4)
CYDY CytoDyn Inc
12/22/2021 4:02:43 PM
Agreed. Have been telling people I (3)
CYDY CytoDyn Inc
12/21/2021 10:49:09 AM
I think the FDA is saying no post h (5)
CYDY CytoDyn Inc
12/15/2021 3:27:51 PM
It all depends on how the DSMC char (4)
CYDY CytoDyn Inc
12/15/2021 2:33:14 PM
DSMC simply tried to do what it was (5)
CYDY CytoDyn Inc
12/15/2021 12:39:02 PM
FDA provides guidance which is not (11)
CYDY CytoDyn Inc
12/14/2021 12:40:24 PM
I have some experience here as both (7)
CYDY CytoDyn Inc
12/14/2021 11:29:36 AM
Correct, FDA is independent of choo (6)
CYDY CytoDyn Inc
12/13/2021 1:39:38 PM
Discussion of rationale for targeti (15)
CYDY CytoDyn Inc
12/09/2021 11:38:58 PM
Right. But then how does LL increas (3)
CYDY CytoDyn Inc
12/09/2021 11:15:41 PM
Nice find. This coincidence is hard (7)
CYDY CytoDyn Inc
12/02/2021 3:46:18 PM
FDA has nothing to do with "release (5)
CYDY CytoDyn Inc
11/08/2021 12:42:25 PM
Agree there are/could be multiple e (4)
CYDY CytoDyn Inc
11/08/2021 10:24:10 AM
ALS is possibly/likely a disease of (3)
CYDY CytoDyn Inc
11/05/2021 2:01:04 PM
Learned a few things: (1) Focusing (5)
CYDY CytoDyn Inc
11/04/2021 4:27:39 PM
Ha, not an expert, just had a littl (8)
CYDY CytoDyn Inc
11/04/2021 11:21:18 AM
NASH is a huge and open market. It' (19)
CYDY CytoDyn Inc
11/03/2021 4:27:28 PM
They sure don't make it easy to fol (5)
CYDY CytoDyn Inc
11/03/2021 10:47:57 AM
Actually it's 75% of those who had (5)
CYDY CytoDyn Inc
11/03/2021 9:32:14 AM
Of the 28 mTNBC patients, 21 (75%) (8)
CYDY CytoDyn Inc
10/23/2021 3:52:58 PM
Hypothalamus not really involved in (4)
CYDY CytoDyn Inc
10/19/2021 3:57:03 PM
Close! Internet searches are fun: h (6)
CYDY CytoDyn Inc
10/19/2021 10:16:50 AM
Recknor is big on biomarkers for Co (1)
CYDY CytoDyn Inc
09/24/2021 10:44:44 PM
Nader Interview https://biotechinte (8)
CYDY CytoDyn Inc
09/24/2021 5:14:12 PM
Maraviroc binding blocks the interm (4)
CYDY CytoDyn Inc
09/15/2021 3:09:38 PM
It's hard to separate those who die (5)
CYDY CytoDyn Inc
08/31/2021 4:33:11 PM
Immunocompromised are also more lik (10)
CYDY CytoDyn Inc
08/23/2021 5:12:28 AM
Very nice! Includes use of maraviro (1)
CYDY CytoDyn Inc
07/29/2021 12:28:28 AM
It's easy to generate hypotheses an (3)
CYDY CytoDyn Inc
07/29/2021 12:01:58 AM
Patterson claims LH treatment on ov (5)
CYDY CytoDyn Inc
07/26/2021 5:44:21 PM
https://www.cdc.gov/nchs/nvss/vsrr (6)
CYDY CytoDyn Inc
07/26/2021 5:17:24 PM
I think Covid has been a bad global (5)
CYDY CytoDyn Inc
07/20/2021 6:40:42 PM
Angelina Jolie did. https://www.cbs (1)
CYDY CytoDyn Inc
07/19/2021 12:18:03 PM
NP has been saying we need at least (10)
CYDY CytoDyn Inc
07/19/2021 9:47:27 AM
Biopsy to see if there is strong ex (2)
CYDY CytoDyn Inc
07/09/2021 12:47:04 PM
I was just telling my brother-in-la (5)
CYDY CytoDyn Inc
07/08/2021 1:14:13 PM
Yes, Our March 23, 2021 response le (11)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Vestis Corporation Investors Urged to Join Securities Class Action
  • Pony AI Secures Permit for Driverless Robotaxi Services Launch
  • Market Focus: T-Mobile, LendingTree, and Molina Insights
  • Discover the Allure of KatsuBet's No Deposit Free Spins Soon
  • Apple Inc. Faces Legal Action Over Alleged Misrepresentation
  • BellRing Brands Under Review for Securities Law Violations
  • Centene Corporation Faces Securities Fraud Lawsuit: Key Insights
  • Lawsuit Against Sarepta Therapeutics: What Investors Should Know
  • Olo Inc. Faces Investigation Over Fiduciary Duty Breaches
  • Understanding the Securities Fraud Lawsuit Against Hims & Hers
  • Investors Urged to Act Following Replimune Group Class Action
  • Understanding the Risks of Private Equity for Everyday Investors
  • Understanding Housing Trends: The Challenges of Rent Indices
  • Key Economic Indicators and Trade Talks Shape Market Focus
  • Exploring the Innovations of Bitcoin Swift and Its Ecosystem
  • Trump's Golden Dome Initiative: A $151 Billion Defense Game-Changer
  • HashJ Expands Services Amidst XRP's $200 Billion Milestone
  • KEENON Robotics Unveils Next-Gen Humanoid Service Robot
  • Team Insta360 and UAE Team Emirates: A New Era in Cycling
  • Assembly Biosciences Shares Progress on Genital Herpes Treatment
  • Pony AI Inc. Secures Permit for Driverless Robotaxi Services
  • Meta Boosts AI Team with OpenAI Expert Shengjia Zhao
  • Bitget Expands Its Influence in Southeast Asia's Crypto Scene
  • Tesla's Upcoming Shareholder Proposals on xAI Investment Strategies
  • Reckitt Benckiser Investors: Join the Class Action Today!
  • Exploring China's Economic Resilience Amid Global Challenges
  • Investors Alert: Join Class Action Against Reckitt Benckiser
  • Investigation Opportunities for Hims & Hers Health Shareholders
  • Investors Alert: Lawsuit Against Tempus AI Affects Shareholders
  • Investors Urged to Claim Losses in Neogen Corporation Lawsuit
  • Reinforcing Trilateral Environmental Collaboration in North America
  • Mercury Insurance to Extend Homeowners Coverage for Californians
  • Klotho Neurosciences, Inc. Innovates for Healthy Aging and Longevity
  • Flywire Corporation Faces Class Action: All You Need to Know
  • Understanding the Easterly ROCMuni Fund Class Action: Key Insights
  • Arnold & Itkin Takes Legal Action Against Chevron Over Explosion
  • Paul Mueller Company Revamps Earnings Report for 2025
  • Westbridge Renewable Energy's Strategic Share Consolidation Details
  • Investigation into Data Breach Claims for Tea App Users
  • Traction Uranium Secures Funding of Up to C$833,400 for Expansion
  • Diginex Moves Forward with Bonus Shares and Shareholder Decisions
  • Faircourt Asset Management Details July Fund Distribution
  • Unveiling Investigations into Crocs, Inc. Stockholder Rights
  • Essential Guide to Enjoying Summer with CASEKOO's Magic Stand
  • Nutex Health Faces Scrutiny After Blue Orca Capital Report
  • Caribou Biosciences Explores Legal Options for Shareholders
  • Chipotle Faces Legal Scrutiny: What Investors Should Know
  • The Growth of $100 in Danaher Corporation Over the Years
  • Unveiling The Stunning Growth of Tesla's Stock Value
  • Black Pearl Equities Initiates Tender Offer for Regional Health Shares
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site